Bavarian Nordic sues Acambis over Smallpox Vaccine IP
Filed in archive Patents and Intellectual Property Rights on August 31, 2005

According to a lawsuit filed by Danish biotech firm Bavarian Nordic, UK-based Acambis met with the firm previously to discuss licensing agreements, but when a $1.9B contract to supply the US government with smallpox vaccine came up for bidding, Acambis ended the discussions with Bavarian Nordic and used the trade secrets it had gleaned to start making its own vaccine, and passing it off as their own.
Read the news report from The Guardian.
Tags: smallpox IPR biotech vaccine acambis bavarian+nordic smallpox+vaccine acambis+over
Vote for Bavarian Nordic sues Acambis over Smallpox Vaccine IP:
|
Rating: 8.00 out of 3 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
